An inappropriate host response to invading bacteria is a critical parameter that often aggravates the outcome of an infection. Staphylococcus aureus is a major human Gram-positive pathogen that causes a wide array of community-and hospital-acquired diseases ranging from superficial skin infections to severe conditions such as staphylococcal toxic shock. Here we find that S. aureus induces inflammatory reactions by modulating the expression and response of the B1 and B2 receptors, respectively. This process is initiated by a chain of events, involving staphylococcalinduced cytokine release from monocytes, bacteria-triggered contact activation, and conversion of bradykinin to its metabolite desArg 9 bradykinin. The data of the present study implicate an important and previously unknown role for kinin receptor regulation in S. aureus infections.
Introduction
Staphylococcus aureus, an important opportunistic Gram-positive human pathogen, is the most common organism isolated from soft-tissue and wound infections. The bacterium can cause a variety of community-and hospital-acquired diseases ranging from relatively benign skin infections, such as furuncles and subcutaneous abscesses, to more severe conditions, including scaled skin syndrome, necrotizing pneumonia, endocarditis, sepsis, and staphylococcal toxic shock syndrome (for reviews see 1, 2 ). In severe conditions, staphylococci may evoke an inappropriate inflammatory host response by modulating so-called "host effector" systems. For instance, S. aureus produces a diverse range of virulence factors contributing to the inflammatory response, among others the enterotoxins and toxic shock syndrome toxin-1 (TSST-1)
that form a class of substances also known as pyrogenic toxin superantigens or PTSAgs (for a review see 3 ) . PTSAgs can induce a profound inflammatory reaction by interacting with MHC class II molecules and T-cell antigen receptors disengaged from the normal antigen-specific signal transduction of T-cells 4, 5 . The resulting inflammatory response is by far greater than antigen-specific activation and leads to pathological levels of pro-inflammatory cytokines 6 .
The human contact system, also known as the kallikrein-kinin cascade or intrinsic pathway of coagulation, is another example of a system that can be targeted and affected during infection 7 . The contact system consists of four factors, three serine proteinases (coagulation factors XI and XII, and plasma kallikrein) and one nonenzymatic co-factor (high molecular weight kininogen). Normally, these factors circulate as zymogens in the blood stream. Contact activation can occur for instance on newly exposed cellular surfaces and is regulated by limited proteolysis. The initial step is activation of coagulation factor XII which converts plasma kallikrein into the active form. Active kallikrein in turn amplifies the activation of factor XII, eventually resulting in clot formation, and the release of bradykinin (BK) from the precursor molecule, high molecular weight kininogen. Previous studies have shown an interaction between S. aureus and the contact system leading to its activation at the bacterial surface 8 . As a result, BK is generated and continuously released from the bacterial cell wall over an extended period of time 8 . Interestingly, this does not apply to all bacterial species. For instance, Streptococcus pneumoniae was not able to activate the contact system in this study 8 . BK and its metabolite desArg 9 BK are potent -4-inflammatory mediators, causing hypotension, increased vascular permeability, edema formation, fever, and pain (for a review see 9 ). Conversion of BK to desArg 9 BK involves the cleavage of a carboxy-terminal arginine by carboxypeptidases of the N and M type, also known as kininases type I 10 . There are two kinin receptors described in humans, B 1 receptor (B1R) and B 2 receptor (B2R) (for a review see 11 ). While BK interacts mainly with B2R, desArg 9 BK is selective for B1R. The two receptors differ also in their expression pattern and pharmacological profile. B2R is constitutively expressed on most cell types and is rapidly internalized upon agonist binding, LPS contents in the stock solutions of the exotoxins (which were diluted 1:10,000 for the assays) were below 1 ng/ml as determined by the Limulus test.
Intracellular cytokine staining
Purified PBMCs were adjusted to 6 x 10 6 cells/ml in RPMI medium. Cells were stimulated with 1% of supernatant from an over night culture of S. aureus (Wood 46) in the presence of Brefeldin A (3 µg/ml, final concentration). Unstimulated cells and bacterial medium alone were used as controls. Cells were fixed and permeabilized as described 16 and then stained with anti-IL-6-FITC, anti-IL-1β-FITC or anti-TNF-α-FITC (R&D Systems, Minneapolis, Minnesota, USA). Samples were analyzed in a FACSCalibur flow cytometer. The monocyte population was identified by FSC/SSC characteristics and positive CD14 staining.
SDS-polyacrylamide gel electrophoresis, Western blotting, and immunoprinting.
Proteins from an overnight culture (S. aureus Wood) were precipitated with 5% (w/v) trichloro-acetic acid (TCA). The precipitates were dissolved in SDS sample buffer and separated by 12,5% (w/v) polyacrylamide gel electrophoresis 17 . Commercially available SEA, SEB, and TSST-1 were used as controls. Proteins were transferred onto nitrocellulose membranes as described 18 and after a blocking step, membranes were probed with antibodies against SEA, SEB and TSST-I (ViroStat, Portland, Maine, USA), diluted 1:200 in the blocking buffer 19 and bound antibodies were detected as described 19 .
RNA isolation, reverse transcription, and quantitative real-time PCR. Total RNA was extracted from IMR-90 cells using the RNA STAT-60 reagent method (TelTest Inc., Friendswood, Texas, USA) as described by the manufacturer. Isolated RNA was DNAse-treated (Ambion, Austin, Texas, USA) and reverse transcribed as described before 20 . Real time quantitative PCR analysis were performed as described Thin-sectioning and transmission electron microscopy. Thin sections were subjected to immuno-labeling as described 22 with the modification that Aurion-BSA (Aurion, Wageningen, the Netherlands) was used as a blocking agent. Briefly, sections were incubated with primary antibodies against B1R or B2R, followed by BK, and applied on a C18 SepPak cartridge (Waters Associates). BK cleavage products were then fractionated by HPLC on a C18 SepPak column as previously described using defined BK fragments as standards 25 .
Immunohistochemical staining of tissue sections. The study was performed in accordance with the declaration of Helsinki and ethical approval to obtain the biopsies was granted by the Human Subjects Review Committee of the University of Toronto.
Biopsies from a local infection site of a patient with soft tissue infection caused by S.
aureus had been collected at surgery, and were immediately snap-frozen and stored at freshly prepared formaldehyde in PBS. The immunohistochemical staining was performed as previously described 26 using 2 µg/ml anti-IL-1β (cocktail of 2-D-8 and 1437-96-15, both murine IgG1, from Dr. H. Towbin, Ciba-Geigy, Basel, Switzerland), and 1:1000 dilution of B1R and B2R specific antibodies 27 , which had been immunopurified from respective polyclonal rabbit antiserum. To control for nonspecific staining, sections that had not been incubated with primary antibodies, were included and were always completely negative. Moreover, no staining was observed when the first antibody was replaced by normal rabbit serum or an unrelated antibody (against curli, an E. coli surface protein). The immunostainings were evaluated and analyzed as described earlier 19 . The whole tissue section was analyzed, which yielded an analyzed cell area (defined by the blue hematoxylin counterstaining) ranging from 
Results
Staphylococcal superantigens induce secretion of pro-inflammatory cytokines from primary human monocytes.
To date, more than 10 different superantigens have been reported to be secreted by S. aureus 28 of which enterotoxin A (SEA), enterotoxin B (SEB), and toxic shock syndrome toxin I (TSST-I) are the best characterized 29 . To investigate a possible role of these toxins in the induction of cytokine secretion from immune cells, purified human peripheral blood mononuclear cells (PBMCs) were incubated with SEA, SEB, TSST-I, or culture media alone. After 24 h, PBMC exudates were collected and analyzed for their IL-1β, IL-6, and TNF-α content, which are the primary cytokines that are produced by these cells 30, 31 . Figure 1A shows that the three toxins triggered a massive secretion of the analyzed cytokines, resulting in cytokine levels that were 10-to 600-fold higher than the background. Staphylococcal toxins are often encoded by accessory genetic elements, including plasmids, prophages, and mobile pathogenicity islands 5 leading to a pattern of toxin expression that may differ from strain to strain 32 .
We therefore wished to determine whether the tested staphylococcal superantigens are expressed and secreted by the S. aureus Wood strain 46, which was used throughout this study. Thus, supernatants from overnight cultures of this strain were subjected to immunodetection following separation by SDS-PAGE and Western blotting. Figure   1B shows that SEB and TSST-I, but not SEA, were secreted into the culture medium under the growth conditions used. As these two toxins are secreted by the Wood strain, we hypothesized that the bacterial supernatants of overnight cultures should also be able to stimulate the secretion of cytokines from PBMCs. To this end, PBMCs were incubated for 24 h with 1% (v/v) supernatants of overnight cultures of S. aureus before cytokine measurements were conducted. As shown in Figure 1C , the treatment led to IL-6 and TNF-α levels in the PBMC exudates that were in the same range as those induced by the toxins alone, while the levels of IL-1β were more than 10-fold increased. To confirm whether the three cytokines were produced in monocytes and not in co-purified B-or T-cells (see also Materials and Methods), cells were stimulated with overnight cultures of S. aureus in the presence of brefeldin A.
Brefeldin A is a fungal toxin that inhibits the transport of secretory proteins between the ER and the cis-Golgi which subsequently leads to an intracellular accumulation of shows that brefeldin A evoked an increase of the intracellular stored cytokines (IL-1β, IL-6, and TNF-α) in monocytes, but not in the B-and T-cell population. Taken
together, these data demonstrate that purified staphylococcal toxins and overnight culture supernatants are able to induce a massive inflammatory response by stimulating monocytes to produce high amounts of pro-inflammatory cytokines.
Induction of B1R and B2R mRNA expression by exudates from PBMCs stimulated with staphylococcal supernatants
The IMR-90 (human fetal lung fibroblasts) cell line is widely used and well-studied for the analysis of kinin receptor regulation in response to inflammatory stimuli 34 .
IMR-90 cells express B1R and B2R at levels and in a ratio reflecting those in vivo.
We therefore used this cell line to investigate B1R and B2R mRNA induction in IL-1β or PBMC exudates induced an increase after two hours, which was about 7-fold over control ( Fig. 2A ) and even higher (approximately 16-fold) when cells were incubated for six hours with PBMC exudates (Fig. 2B) . Co-incubation of PBMC exudates with BK or desArg 9 BK induced in a time-dependent manner a minor downregulation of B1R mRNA expression. Figures 2C and 2D show that exposure to BK, but not to desArg 9 BK, led to a decrease in B2R mRNA levels, while treatment with Thus, the data suggest that even though stimulation of IMR-90 cells leads to increased protein levels of both receptors, only the B1R is upregulated at the cell surface. The finding can be explained by different trafficking mechanisms that target the receptor to the cell membrane or other yet unknown mechanism.
Conversion of BK from a B2R-agonist to a B1R-agonist
Previous work has shown that S. aureus isolates from patients with septic shock, activate the human contact system. As a result BK is generated and continuously released from the bacterial surface at a rate that is sufficient to induce an activation of B2R in transfected CHO cells 8 . Similar findings were also observed in the present study when the Wood strain was tested. It is important to mention that so far there have been no reports in the literature showing that staphylococcal proteinases are able to release desArg 9 BK from the precursor molecules or to remove the carboxy-terminal arginine-residue from BK, thereby converting the peptide from a B2R to a B1R agonist. Interestingly, staphylococcal secretion products were able to stimulate monocytes to release pro-inflammatory cytokines followed by a massive upregulation of B1Rs on IMR-90 cells. Moreover, when the stimulation occurred in the presence of desArg 9 BK, a synergistic effect was recorded. We therefore investigated whether BK released from the staphylococcal surface may be converted to desArg 9 BK by a eukaryotic-driven mechanism, for instance due to cleavage by a cell surfacebound endopeptidase. In order to address this question, we employed rabbit superior mesenteric artery smooth muscle cells which have been intensively studied in respect to their pharmacology 15, 35 . In contrast to IMR-90 cells, the smooth muscle cells are a primary vascular cell line that has retained much of its original phenotype and basally expresses B1Rs and B2Rs at their surface 15, 35 . Figure 5D ).
We next sought to determine whether the response of rabbit smooth muscles cells to treatment with BK is solely BK-mediated or partially caused by the newly formed desArg 9 BK. To this end, we employed a cell proliferation assay, since it has been shown that both kinins (BK and desArg 9 BK) exert mitogenic effects 36 . The assay was also chosen since it requires a relatively long agonist incubation time and, therefore, provides an opportunity for the formation and action of desArg 9 BK following BK addition. This is in contrast to other methods such as assays of intracellular Ca 2+ mobilization, which occurs within seconds. Figure 6A shows that treatment of rabbit smooth muscle cells with desArg 9 BK or BK caused a significant increase in Figure 6C shows that all inhibitors clearly impaired BK-prompted thymidine incorporation, while having minimal or no effect on basal incorporation.
These data provide direct evidence that the mitogenic effect of BK is partially caused by the conversion of BK to desArg 9 BK, generated upon interaction of BK with carboxypeptidases from smooth muscle cells.
Western blot analysis of toxins secreted from clinical S. aureus strains
Next we tested supernatants from overnight cultures of five clinical staphylococcal strains for their toxin expression. Figures 7A and B (lanes 2 -6) show that all strains tested produced TSST-1 and SEB, though the amount of secreted toxin seems to vary from strain to strain. Similar results were obtained, when the expression of SEA in the clinical isolates was investigated (data not shown). Strain Mu50 (ATCC 700699) whose genome has been completely sequenced, was used as a positive control and was found to express TSST-1 and SEB ( Fig. 7A + B ; lane 1) as well as SEA (data not shown).
Analysis of B1R and B2R expression on tissue biopsies from a patient suffering from a staphylococcal soft tissue infection
To assess the expression of B1R and B2R in vivo during an infection, we analyzed tissue biopsies collected from a patient with a soft tissue infection caused by the 9730 strain ( Fig. 7A + B, lane 2) . For comparison, samples were collected from two sites including the epicenter of the infection and a more distal site. Histological examination of the biopsies showed that the tissue sections had different morphologies with more signs of inflammation and loss of tissue structure in biopsies obtained from the epi-center of the infectious site (data not shown).
Further immuno-histochemical analysis revealed that both B1R and B2R were expressed at the local site of infection. Interestingly, the level of B1R expression was more than 3-fold higher at the epicenter as compared to the section from the more distal site (Fig. 7C) . In contrast, equal levels were noted for the B2R in the two groups of biopsies. To assess the degree of inflammation in the biopsies, the sections were -15- Based on the results of the present study the following model is suggested. At the infectious site invading monocytes become activated by staphylococcal toxins and secrete pro-inflammatory cytokines that induce an up-regulation of the B1R at the infectious focus. Plasma exudation into the infectious site will trigger contact activation and the formation of BK. BK can bind to B2R and trigger its downregulation or be converted to the B1R agonist, desArg 9 BK, which subsequently leads to an activation and an additional up-regulation of B1R.
